New drug aims to restore movement after spinal cord injury
Disease control
Recruiting now
This study tests an experimental drug called NVG-291 in 40 people with spinal cord injuries. The goal is to see if it can improve nerve signals and movement, like walking speed and hand function. Participants receive either the drug or a placebo, and neither they nor the doctors …
Phase: PHASE1, PHASE2 • Sponsor: NervGen Pharma • Aim: Disease control
Last updated May 22, 2026 13:53 UTC